Therapeutic potential of methylxanthine drug on alpha synuclein protein in Parkinson's disease
Nishant Kumar Rana, Neha Srivastava, Bhupendra Kumar, Abhishek Pathak, Vijaya Nath Mishra
The paper identifies methylxanthine as a potential inhibitor of SNCA protein through computational analysis, suggesting its therapeutic potential for Parkinson's disease prevention.
bioRxiv · Dec 20, 2021 · PreprintBioinformatics